J. Safra Sarasin Holding Ag Apellis Pharmaceuticals, Inc. Transaction History
J. Safra Sarasin Holding Ag
- $5.47 Trillion
- Q2 2024
A detailed history of J. Safra Sarasin Holding Ag transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 37,543 shares of APLS stock, worth $1.34 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
37,543Holding current value
$1.34 Million% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding APLS
# of Institutions
299Shares Held
113MCall Options Held
5.21MPut Options Held
691K-
Wellington Management Group LLP Boston, MA16.4MShares$584 Million0.11% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$414 Million15.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$396 Million5.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$350 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$207 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.92B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...